Lung Cancer
Conference Coverage
Promising treatment option for incurable lung cancer described as ‘significant’
Investigators suggest this combo should be standard therapy for NSCLC going forward.
Conference Coverage
Adagrasib shows durable benefit in KRAS-mutated NSCLC
“Our patients benefited clinically from this agent, and it appears to have improved overall survival.”
From the Journals
Immunotherapy treatment combo charts new course for resectable NSCLC treatment
Three cycles of neoadjuvant nivolumab plus chemotherapy improved long-term clinical outcomes in resectable stage IB-IIIA NSCLC.
Recap
Using Bronchoscopy to Optimize Targeted Therapy in Non-Small Cell Lung Cancer
The expanding treatment landscape in non–small cell lung cancer has deepened the collaboration...
From the Journals
Can lung cancer ID be as easy as breathing into an analyzer?
Breathomics testing is considered a promising lung cancer screening tool.
From the Journals
Some smokers don’t get lung cancer; genetics might explain it
These people have genes that help limit mutations to DNA that would turn cells malignant and make them grow into tumors.
From the Journals
Improved cancer survival in states with ACA Medicaid expansion
The 2-year overall survival increased from 80.6% before the ACA to 82.2% post ACA in expansion states and from 78.7% to 80% in nonexpansion states...
From the Journals
Women with lung cancer live longer than men
“In this first Australian prospective study of lung cancer survival comparing men and women, we found that men had a 43% greater risk of dying...
From the Journals
Clinical chest images power up survival prediction in lung cancer
“The results of this study demonstrate promising results supportive of the notion that combining clinical and imaging data points can help build a...
Feature
Fifth COVID shot recommended for patients with cancer